ONtrack Biomedical AG
Non-invasive assays for the screening, diagnosis and monitor
ONtrack Diagnostics is a medtech company focusing on the development of non-invasive assays for the screening, diagnosis and monitoring of oncological diseases. Our first product is a urine assay for the screening of prostate cancer.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
27.04.2023
The Biomedical Entrepreneurship ecosystem: Turning cutting-edge research into viable ventures (venturelab.swiss)
25.08.2022
"Innovation needs diversity" — Interview with Maria Olivares of the Innovation Hub at the University of Zürich (venturelab.swiss)
No milestones
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
ONtrack Biomedical AG
Non-invasive assays for the screening, diagnosis and monitor
Headquarter:
Schlieren
Foundation Date:
January 2023
Technology:
- Medtech
Sectors:
- Cancer
- Diagnostics
- Medtech
- Screening
Support received
